Kerry C Cho, MD
Nephrology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 4
- Since medical school
- 30 years
- Js Weill Medical College, Cornell University, 1996
Offices
4 locations · University of California San Francisco · UCSF Medical Group Business Services · Regents of the University of California
Hospitals listed: 552719 · 552733 · Marinhealth Medical Center · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cho’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A70525 · Current
Licensed to practise in California · since 1999 · expires 2027-08-31 · Cornell University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Nephrology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$100,030
Medicare paid this office $100,030 for 238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 92 | $22,591 | $122 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $13,039 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $12,336 | $105 |
| Hemodialysis procedure with physician evaluation | 47 | $7,106 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $5,123 | $70 |
See all 11 services
| Long return visit (40+ min) | 92 | $22,591 | $122 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $13,039 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $12,336 | $105 |
| Hemodialysis procedure with physician evaluation | 47 | $7,106 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $5,123 | $70 |
| Return visit (30+ min) | 55 | $4,808 | $75 |
| New patient visit (60+ min) | 32 | $4,798 | $150 |
| Dialysis procedure including 1 evaluation | 18 | $4,225 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,002 | $154 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 100 | $1,955 | $15 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 28 | $1,308 | $28 |
Who their Medicare patients are
238 Original Medicare patients in 2024. Average age 71 · Under 65 20% · 85 and older 14% · Women 41% · Also on Medicaid 42% · Health risk score 4.40. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 54% · Coronary heart disease 44% · Heart failure 44% · Atrial fibrillation 36% · Depression 27% · Cancer 21% · Stroke 19% · COPD 15% · Dementia 13%.
The office billed $589,018, Medicare allowed $128,675 and paid $100,030; for 1,040 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 238 | 1,040 | 71 | 4.40 | $589,018 | $100,030 |
| 2023 | 236 | 962 | 73 | 5.05 | $540,842 | $95,065 |
| 2022 | 200 | 1,071 | 70 | 4.82 | $529,801 | $93,300 |
| 2021 | 182 | 1,046 | 71 | 4.73 | $483,922 | $89,135 |
| 2020 | 188 | 890 | 70 | 5.02 | $510,641 | $85,880 |
| 2019 | 232 | 1,059 | 69 | 6.65 | $692,236 | $112,946 |
| 2018 | 231 | 1,068 | 69 | 5.74 | $661,507 | $112,699 |
| 2017 | 251 | 1,313 | 70 | 4.93 | $641,505 | $113,566 |
| 2016 | 240 | 1,133 | 70 | 6.00 | $642,521 | $114,011 |
| 2015 | 254 | 1,411 | 68 | 5.64 | $670,327 | $119,857 |
| 2014 | 227 | 1,270 | 68 | 5.12 | $682,801 | $119,096 |
| 2013 | 230 | 1,020 | 67 | 4.94 | $588,136 | $109,210 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $26,124 | $107 |
| Long return visit (40+ min) | 58 | $11,503 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,013 | $156 |
| Hemodialysis procedure with physician evaluation | 53 | $7,447 | $64 |
| Dialysis procedure including 1 evaluation | 26 | $6,225 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,426 | $70 |
| Return visit (30+ min) | 34 | $3,880 | $83 |
| Short return visit (20+ min) | 19 | $1,205 | $57 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $17,051 | $91 |
| Long return visit (40+ min) | 58 | $13,005 | $120 |
| Hemodialysis procedure with physician evaluation | 51 | $6,998 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,820 | $176 |
| Dialysis procedure including 1 evaluation | 17 | $4,807 | $79 |
| Return visit (30+ min) | 34 | $4,082 | $82 |
| New patient visit (60+ min) | 19 | $2,992 | $157 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $2,675 | $9 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $625 | $28 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $16,051 | $91 |
| Home dialysis services per month (20 years or older) | 12 | $15,869 | $264 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $15,515 | $272 |
| Long return visit (40+ min) | 41 | $7,874 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,823 | $175 |
| Hemodialysis procedure with physician evaluation | 39 | $5,681 | $65 |
| Dialysis procedure including 1 evaluation | 19 | $3,541 | $77 |
| Return visit (30+ min) | 28 | $2,517 | $81 |
| New patient visit (60+ min) | 13 | $2,147 | $165 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $16,297 | $94 |
| Hemodialysis procedure with physician evaluation | 42 | $6,550 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,203 | $182 |
| Dialysis procedure including 1 evaluation | 20 | $5,789 | $79 |
| Long return visit (40+ min) | 40 | $5,577 | $93 |
| Return visit (30+ min) | 19 | $1,504 | $68 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,432 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $977 | $65 |
2019: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $21,818 | $93 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $16,347 | $259 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $13,106 | $215 |
| Hemodialysis procedure with physician evaluation | 80 | $12,730 | $66 |
| Long return visit (40+ min) | 70 | $12,383 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $9,248 | $174 |
| Dialysis procedure including 1 evaluation | 25 | $7,755 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,044 | $65 |
2018: 8 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $21,346 | $216 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $20,042 | $92 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 17 | $14,314 | $256 |
| Dialysis procedure including 1 evaluation | 40 | $10,135 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,983 | $178 |
| Long return visit (40+ min) | 56 | $8,374 | $94 |
| Hemodialysis procedure with physician evaluation | 64 | $8,182 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $906 | $65 |
2017: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 97 | $23,504 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $21,625 | $216 |
| Long return visit (40+ min) | 64 | $10,570 | $95 |
| Hemodialysis procedure with physician evaluation | 64 | $10,073 | $64 |
| Dialysis procedure including 1 evaluation | 31 | $8,168 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,019 | $180 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $2,689 | $168 |
| Dialysis services, per day, less than full month service (20 years or older) | 17 | $2,495 | $7 |
| New patient visit (60+ min) | 14 | $2,101 | $150 |
| New patient visit (45+ min) | 11 | $1,199 | $109 |
| Return visit (30+ min) | 20 | $949 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $775 | $65 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 101 | $23,452 | $91 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $21,935 | $215 |
| Hemodialysis procedure with physician evaluation | 82 | $13,122 | $63 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 11 | $9,469 | $256 |
| Long return visit (40+ min) | 39 | $8,172 | $94 |
| Dialysis procedure including 1 evaluation | 22 | $7,881 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,055 | $176 |
| Return visit (30+ min) | 36 | $3,835 | $67 |
| New patient visit (60+ min) | 14 | $1,993 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,091 | $64 |
2015: 10 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $26,912 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 116 | $24,724 | $94 |
| Hemodialysis procedure with physician evaluation | 99 | $13,644 | $64 |
| Long return visit (40+ min) | 48 | $11,448 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,087 | $178 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $5,956 | $259 |
| Dialysis procedure including 1 evaluation | 24 | $5,890 | $77 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $5,289 | $171 |
| Return visit (30+ min) | 33 | $3,528 | $67 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $2,431 | $6 |
2014: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 17 | $32,284 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $21,128 | $92 |
| Hemodialysis procedure with physician evaluation | 78 | $12,378 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,175 | $175 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $9,819 | $218 |
| Long return visit (40+ min) | 33 | $7,615 | $94 |
| Dialysis procedure including 1 evaluation | 20 | $5,954 | $78 |
| Return visit (30+ min) | 38 | $4,190 | $67 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $2,035 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,544 | $64 |
2013: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 21 | $26,121 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $21,740 | $90 |
| Hemodialysis procedure with physician evaluation | 84 | $13,369 | $62 |
| Dialysis procedure including 1 evaluation | 28 | $9,457 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $9,052 | $174 |
| Long return visit (40+ min) | 51 | $8,746 | $92 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $7,298 | $215 |
| Return visit (30+ min) | 32 | $2,855 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,213 | $60 |
| Other inpatient or outpatient dialysis procedure | 17 | $1,612 | $73 |
Medicaid work
$9,601 in 2023
Medicaid paid $9,601 for 98 billed services this clinician did in 2023, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 98 | $9,601 |
| 2023 | 98 | 1 | 19 | $9,601 |
| 2022 | 30 | 1 | 16 | $1,702 |
| 2019 | 196 | 2 | 23 | $11,875 |
| 2018 | 119 | 1 | 15 | $6,822 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 30 | $1,702 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 106 | $6,058 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 90 | $5,817 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 119 | $6,822 |
Drugs they prescribed that Part D paid
$165,504
Pharmacies billed $165,504 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 600) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
501 generic and 99 brand-name prescriptions · $165,504 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 35 | $41,904 | $1,197 |
| Jardiance | 20 | $34,675 | $1,734 |
| Sevelamer Carbonate | 24 | $5,249 | $219 |
| Calcium Acetate | 17 | $3,331 | $196 |
| Losartan | 33 | $387 | $12 |
See all 16 drugs
| Farxiga | 35 | $41,904 | $1,197 |
| Jardiance | 20 | $34,675 | $1,734 |
| Sevelamer Carbonate | 24 | $5,249 | $219 |
| Calcium Acetate | 17 | $3,331 | $196 |
| Losartan | 33 | $387 | $12 |
| Olmesartan Medoxomil | 17 | $379 | $22 |
| Carvedilol | 31 | $333 | $11 |
| Amlodipine Besylate | 52 | $326 | $6 |
| Furosemide | 32 | $300 | $9 |
| Chlorthalidone | 17 | $296 | $17 |
| Tamsulosin | 16 | $269 | $17 |
| Lisinopril | 27 | $223 | $8 |
| Benazepril | 14 | $166 | $12 |
| Allopurinol | 15 | $165 | $11 |
| Atorvastatin | 24 | $132 | $6 |
| Finasteride | 13 | $124 | $10 |
Year by year
| 2024 | 600 | 108 | 0% (0) | 17% | $165,504 |
| 2023 | 488 | 87 | 0% (0) | None | $165,487 |
| 2022 | 451 | 81 | 0% (0) | None | $130,795 |
| 2021 | 412 | 75 | 0% (0) | 19% | $117,076 |
| 2020 | 390 | 68 | 0% (0) | 21% | $90,697 |
| 2019 | 425 | 73 | 0% (0) | None | $130,812 |
| 2018 | 486 | 77 | 0% (0) | None | $103,235 |
| 2017 | 458 | 65 | 0% (0) | 15% | $84,310 |
| 2016 | 461 | 68 | None | 23% | $86,916 |
| 2015 | 442 | 65 | None | 30% | $123,813 |
| 2014 | 436 | 66 | 0% (0) | 30% | $103,210 |
| 2013 | 536 | 59 | None | None | $70,171 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Farxiga | 39 | $55,898 | $1,433 |
| Sevelamer Carbonate | 18 | $9,676 | $538 |
| Losartan | 40 | $833 | $21 |
| Amlodipine Besylate | 53 | $598 | $11 |
| Tamsulosin | 20 | $551 | $28 |
| Metoprolol | 12 | $461 | $38 |
| Carvedilol | 33 | $460 | $14 |
| Atorvastatin | 25 | $362 | $14 |
| Finasteride | 12 | $248 | $21 |
| Furosemide | 23 | $171 | $7 |
| Lisinopril | 22 | $162 | $7 |
| Omeprazole | 12 | $78 | $6 |
2022: 13 drugs
| Farxiga | 22 | $34,927 | $1,588 |
| Sevelamer Carbonate | 11 | $4,063 | $369 |
| Eplerenone | 12 | $1,834 | $153 |
| Tamsulosin | 28 | $688 | $25 |
| Carvedilol | 29 | $660 | $23 |
| Labetalol | 12 | $651 | $54 |
| Losartan | 33 | $440 | $13 |
| Amlodipine Besylate | 45 | $426 | $9 |
| Furosemide | 28 | $351 | $13 |
| Atorvastatin | 19 | $146 | $8 |
| Lisinopril | 17 | $104 | $6 |
| Hydrochlorothiazide | 15 | $43 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $35 | $3 |
2021: 12 drugs
| Farxiga | 21 | $29,115 | $1,386 |
| Eplerenone | 13 | $3,083 | $237 |
| Calcium Acetate | 13 | $2,270 | $175 |
| Labetalol | 13 | $1,190 | $92 |
| Olmesartan Medoxomil | 17 | $1,098 | $65 |
| Amlodipine Besylate | 46 | $494 | $11 |
| Losartan | 29 | $450 | $16 |
| Carvedilol | 19 | $365 | $19 |
| Furosemide | 28 | $287 | $10 |
| Tamsulosin | 15 | $242 | $16 |
| Lisinopril | 22 | $181 | $8 |
| Atorvastatin | 18 | $153 | $9 |
2020: 13 drugs
| Aranesp | 11 | $13,166 | $1,197 |
| Sevelamer Carbonate | 12 | $9,308 | $776 |
| Veltassa | 11 | $7,692 | $699 |
| Calcium Acetate | 16 | $2,527 | $158 |
| Potassium Chloride | 12 | $462 | $39 |
| Losartan | 36 | $450 | $12 |
| Hydralazine | 11 | $361 | $33 |
| Amlodipine Besylate | 43 | $335 | $8 |
| Carvedilol | 18 | $323 | $18 |
| Atorvastatin | 18 | $287 | $16 |
| Tamsulosin | 17 | $245 | $14 |
| Furosemide | 20 | $190 | $9 |
| Lisinopril | 11 | $84 | $8 |
2019: 14 drugs
| Renvela | 11 | $40,118 | $3,647 |
| Sevelamer Carbonate | 17 | $19,914 | $1,171 |
| Calcium Acetate | 18 | $1,831 | $102 |
| Bumetanide | 20 | $1,700 | $85 |
| Labetalol | 13 | $1,493 | $115 |
| Tamsulosin | 18 | $669 | $37 |
| Losartan | 37 | $404 | $11 |
| Amlodipine Besylate | 43 | $347 | $8 |
| Carvedilol | 19 | $280 | $15 |
| Hydralazine | 12 | $270 | $23 |
| Furosemide | 16 | $196 | $12 |
| Atorvastatin | 14 | $178 | $13 |
| Lisinopril | 16 | $65 | $4 |
| Hydrochlorothiazide | 11 | $27 | $2 |
2018: 13 drugs
| Sevelamer Carbonate | 29 | $30,989 | $1,069 |
| Calcium Acetate | 26 | $4,603 | $177 |
| Labetalol | 20 | $1,256 | $63 |
| Bumetanide | 12 | $1,152 | $96 |
| Tamsulosin | 21 | $843 | $40 |
| Atorvastatin | 21 | $474 | $23 |
| Losartan | 45 | $432 | $10 |
| Hydralazine | 23 | $341 | $15 |
| Amlodipine Besylate | 42 | $272 | $6 |
| Furosemide | 25 | $200 | $8 |
| Benazepril | 14 | $170 | $12 |
| Lisinopril | 13 | $104 | $8 |
| Hydrochlorothiazide | 22 | $67 | $3 |
2017: 12 drugs
| Renvela | 18 | $49,000 | $2,722 |
| Calcium Acetate | 47 | $6,416 | $137 |
| Labetalol | 15 | $812 | $54 |
| Atorvastatin | 31 | $664 | $21 |
| Tamsulosin | 15 | $643 | $43 |
| Benazepril | 27 | $270 | $10 |
| Losartan | 40 | $213 | $5 |
| Amlodipine Besylate | 44 | $204 | $5 |
| Lisinopril | 16 | $176 | $11 |
| Hydralazine | 18 | $148 | $8 |
| Furosemide | 19 | $106 | $6 |
| Hydrochlorothiazide | 28 | $75 | $3 |
2016: 13 drugs
| Renvela | 26 | $44,073 | $1,695 |
| Sensipar | 15 | $24,698 | $1,647 |
| Calcium Acetate | 28 | $4,943 | $177 |
| Warfarin | 24 | $955 | $40 |
| Atorvastatin | 35 | $875 | $25 |
| Tamsulosin | 14 | $666 | $48 |
| Lidocaine-Prilocaine | 16 | $613 | $38 |
| Furosemide | 30 | $359 | $12 |
| Amlodipine Besylate | 43 | $354 | $8 |
| Losartan | 30 | $245 | $8 |
| Lisinopril | 15 | $132 | $9 |
| Benazepril | 21 | $118 | $6 |
| Hydrochlorothiazide | 23 | $43 | $2 |
2015: 13 drugs
| Renvela | 31 | $56,447 | $1,821 |
| Sensipar | 21 | $33,317 | $1,587 |
| Calcium Acetate | 24 | $3,434 | $143 |
| Labetalol | 18 | $1,593 | $89 |
| Hydralazine | 12 | $557 | $46 |
| Furosemide | 52 | $468 | $9 |
| Amlodipine Besylate | 37 | $384 | $10 |
| Atorvastatin | 16 | $334 | $21 |
| Warfarin | 13 | $327 | $25 |
| Benazepril | 28 | $294 | $10 |
| Losartan | 16 | $193 | $12 |
| Lisinopril | 11 | $81 | $7 |
| Hydrochlorothiazide | 17 | $39 | $2 |
2014: 12 drugs
| Renvela | 24 | $52,101 | $2,171 |
| Sensipar | 17 | $18,188 | $1,070 |
| Fosrenol | 11 | $8,782 | $798 |
| Calcium Acetate | 26 | $4,449 | $171 |
| Labetalol | 21 | $1,795 | $85 |
| Atorvastatin | 22 | $532 | $24 |
| Benazepril | 27 | $449 | $17 |
| Amlodipine Besylate | 37 | $376 | $10 |
| Furosemide | 55 | $373 | $7 |
| Losartan | 16 | $241 | $15 |
| Simvastatin | 18 | $146 | $8 |
| Lisinopril | 12 | $81 | $7 |
2013: 12 drugs
| Renvela | 30 | $32,443 | $1,081 |
| Calcium Acetate | 19 | $3,853 | $203 |
| Crestor | 12 | $2,059 | $172 |
| Atorvastatin | 19 | $826 | $43 |
| Amlodipine Besylate | 55 | $662 | $12 |
| Benazepril | 27 | $525 | $19 |
| Losartan | 23 | $511 | $22 |
| Simvastatin | 35 | $324 | $9 |
| Furosemide | 52 | $313 | $6 |
| Lisinopril | 31 | $208 | $7 |
| Carvedilol | 13 | $124 | $10 |
| Metoprolol | 13 | $120 | $9 |
Money from drug and device companies
$50 in 2019
A payment is not proof that care is biased.
| TerSera Therapeutics | Varubi | $50 | 2 payments
|
See all 2 published payments
| TerSera Therapeutics | Meals · 2019-05-24 | Varubi | $25 |
| TerSera Therapeutics | Meals · 2019-05-22 | Varubi | $25 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1861434318
- Licence
- CA A70525California A70525: Current · expires 2027-08-31
- Trained
- Js Weill Medical College, Cornell University, 1996 · 30 years ago
- Group
- University of California San Francisco · UCSF Medical Group Business Services · Regents of the University of California
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A705250
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-06-11
- NPI last updated
- 2020-04-23
- NPI record certified
- 2020-04-23
This is when the NPI record was last certified, not a medical board exam.